PVI
PFE icon

Pura Vida Investments’s Pfizer PFE Stock Holding History

Pura Vida Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,000
Closed -$5.12M – 145
2022
Q4 		$5.12M Hold
100,000
– – 0.26% 88
2022
Q3 		$4.38M Buy
+100,000
New +$4.86M 0.25% 97
2017
Q4 		– Sell
-527,000
Closed -$17.9M – 90
2017
Q3 		$17.9M Buy
+527,000
New +$16.9M 5.22% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pura Vida Investments's PFE Position: Q4 2022 in Review

Pura Vida Investments sold out of Pfizer (PFE) in Q4 2022, closing a stake of 50,000 shares — an estimated $2.4M sold.

Pura Vida Investments first reported a position in PFE in Q2 2015 and held it in 7 quarters. The position peaked at $8.99M in Q4 2021. 3,267 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Pura Vida Investments reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Pfizer shares in Q4 2022, an estimated $2.4M.
  • Pura Vida Investments first reported a position in Pfizer in Q2 2015 and held it in 7 quarters.
  • Pura Vida Investments's Pfizer position peaked at $8.99M in Q4 2021.
  • 3,267 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.